Search research articles
Contact Us
Filters
Showing results (131-140 of 193) with videos related to
Page
of 20
Sort By:
Clinical Colorectal Cancer
|
December 23, 2022
Long-term Survival Update and Extended RAS Mutational Analysis of the CAIRO2 Trial: Addition of Cetuximab to CAPOX/Bevacizumab in Metastatic Colorectal Cancer
Sanne Ten Hoorn, Linda Mol, Dirkje W Sommeijer, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 29, 2026
Mapping the anatomical landscape of colorectal tumours: Location-specific efficacy of anti-epidermal growth factor receptor antibodies: Pooled analysis of randomised trials
Kenta Iguchi, Kentaro Yamazaki, Toshihiro Misumi, et al.
JNCI Cancer Spectrum
|
April 25, 2025
Associations between early tumor shrinkage/depth of response and survival from the ARCAD database
Hideaki Bando, Yuriko Takeda, Toshihiro Misumi, et al.
The Oncologist
|
August 20, 2025
First-line PD-1 +/- CTLA-4 blockade in patients with deficient mismatch repair and/or microsatellite instability-high metastatic colorectal cancer
Vincenzo Nasca, Gabriele Tinè, Julien Taieb, et al.
BMC Cancer
|
July 19, 2012
Beyond KRAS mutation status: influence of KRAS copy number status and microRNAs on clinical outcome to cetuximab in metastatic colorectal cancer patients
Leonie J M Mekenkamp, Jolien Tol, Jeroen R Dijkstra, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
November 8, 2024
Development of a prediction model for clinically-relevant fatigue: a multi-cancer approach
Dhirendra Adiprakoso, Dimitris Katsimpokis, Simone Oerlemans, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 29, 2016
WRN Promoter CpG Island Hypermethylation Does Not Predict More Favorable Outcomes for Patients with Metastatic Colorectal Cancer Treated with Irinotecan-Based Therapy
Linda J W Bosch, Yanxin Luo, Victoria V Lao, et al.
Clinical Pharmacology and Therapeutics
|
February 11, 2026
Assessing Overall Survival Benefits in Advanced Cancers: The Role of External Comparator Cohort Studies with Real-World Data
Francesco Pignatti, Tarec Christoffer El-Galaly, Martin Kaiser, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
May 28, 2020
Modeling Personalized Adjuvant TreaTment in EaRly stage coloN cancer (PATTERN)
Gabrielle Jongeneel, Marjolein J E Greuter, Felice N van Erning, et al.
International Journal of Cancer
|
August 8, 2024
Benefit of adjuvant chemotherapy on recurrence free survival per consensus molecular subtype in stage III colon cancer
Simone van de Weerd, Arezo Torang, Inge van den Berg, et al.
Page
of 20
Search research articles
Search
Showing results (131-140 of 193) with videos related to
Sort By:
Page
of 20
Clinical Colorectal Cancer
|
December 23, 2022
Long-term Survival Update and Extended RAS Mutational Analysis of the CAIRO2 Trial: Addition of Cetuximab to CAPOX/Bevacizumab in Metastatic Colorectal Cancer
Sanne Ten Hoorn, Linda Mol, Dirkje W Sommeijer, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 29, 2026
Mapping the anatomical landscape of colorectal tumours: Location-specific efficacy of anti-epidermal growth factor receptor antibodies: Pooled analysis of randomised trials
Kenta Iguchi, Kentaro Yamazaki, Toshihiro Misumi, et al.
JNCI Cancer Spectrum
|
April 25, 2025
Associations between early tumor shrinkage/depth of response and survival from the ARCAD database
Hideaki Bando, Yuriko Takeda, Toshihiro Misumi, et al.
The Oncologist
|
August 20, 2025
First-line PD-1 +/- CTLA-4 blockade in patients with deficient mismatch repair and/or microsatellite instability-high metastatic colorectal cancer
Vincenzo Nasca, Gabriele Tinè, Julien Taieb, et al.
BMC Cancer
|
July 19, 2012
Beyond KRAS mutation status: influence of KRAS copy number status and microRNAs on clinical outcome to cetuximab in metastatic colorectal cancer patients
Leonie J M Mekenkamp, Jolien Tol, Jeroen R Dijkstra, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
November 8, 2024
Development of a prediction model for clinically-relevant fatigue: a multi-cancer approach
Dhirendra Adiprakoso, Dimitris Katsimpokis, Simone Oerlemans, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 29, 2016
WRN Promoter CpG Island Hypermethylation Does Not Predict More Favorable Outcomes for Patients with Metastatic Colorectal Cancer Treated with Irinotecan-Based Therapy
Linda J W Bosch, Yanxin Luo, Victoria V Lao, et al.
Clinical Pharmacology and Therapeutics
|
February 11, 2026
Assessing Overall Survival Benefits in Advanced Cancers: The Role of External Comparator Cohort Studies with Real-World Data
Francesco Pignatti, Tarec Christoffer El-Galaly, Martin Kaiser, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
May 28, 2020
Modeling Personalized Adjuvant TreaTment in EaRly stage coloN cancer (PATTERN)
Gabrielle Jongeneel, Marjolein J E Greuter, Felice N van Erning, et al.
International Journal of Cancer
|
August 8, 2024
Benefit of adjuvant chemotherapy on recurrence free survival per consensus molecular subtype in stage III colon cancer
Simone van de Weerd, Arezo Torang, Inge van den Berg, et al.
Page
of 20